August 4, 2026

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 28.66% Potential Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology industry, offers a compelling investment opportunity amidst the dynamic healthcare sector. With a market capitalization..

Sotera Health Company (SHC) Stock Analysis: Evaluating a 13.64% Potential Upside and Strong Buy Ratings

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Unpacking a 40% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biotech sector with its focus on developing therapies for rare and debilitating diseases. With a market..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Significant Upside Potential with 138% Growth Prospects

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its promising growth potential in the healthcare sector. Headquartered in Durham, North Carolina, BioCryst..

MiMedx Group, Inc (MDXG) Stock Analysis: Unpacking a 54% Potential Upside in Biotech

MiMedx Group, Inc. (NASDAQ: MDXG) stands as a compelling figure in the biotech sector, boasting a market capitalization of $622.4 million. Specializing in the development and..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: What Investors Need to Know About Its 44.7% Revenue Growth

Investors have shown increasing interest in Establishment Labs Holdings Inc (NASDAQ: ESTA) as the company continues to make waves in the healthcare sector, particularly within the..

IDEAYA Biosciences (IDYA) Stock Analysis: Unpacking a 51% Potential Upside with Strong Buy Ratings

IDEAYA Biosciences, Inc. (IDYA), a prominent player in the biotechnology sector, is capturing investor attention with its innovative precision medicine oncology solutions and a robust market..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering a 16.68% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) presents an intriguing opportunity for investors with its focus on groundbreaking therapies for autoimmune diseases. Based in Edmonton, Canada, this biopharmaceutical..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A 43.66% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has captured investor attention with its promising growth prospects and a substantial potential upside...

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with Strategic Insights

agilon health, inc. (NYSE: AGL), a key player in the medical care facilities sector, is facing a turbulent market environment. With a market capitalization of $1.57..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 21% Upside Potential

UFP Technologies, Inc. (NASDAQ: UFPT) has become a compelling contender in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.07..

Mineralys Therapeutics (MLYS) Stock Analysis: Exploring a 90% Potential Upside in the Biotech Space

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning name in the biotechnology sector focused on addressing diseases driven by dysregulated aldosterone, has been making waves with its..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Evaluating the Healthcare Specialist with a Strong ROE and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD), a significant player in the U.S. healthcare sector, specifically within medical care facilities, presents an intriguing proposition for investors seeking..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 38% Potential Upside

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, is capturing investor attention with its impressive growth prospects and strategic focus on central nervous..

Evotec SE (EVO) Stock Analysis: Unveiling Nearly 100% Upside Potential Amidst Strong Strategic Collaborations

Evotec SE (EVO), a prominent player in the healthcare sector, primarily operates in the specialty and generic drug manufacturing industry. Headquartered in Hamburg, Germany, the company..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking Growth Potential with a 7.83% Upside

Progyny, Inc. (NASDAQ: PGNY) is capturing investor attention as a unique player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Healthcare Diagnostics Frontier with a Market Cap of $3.02 Billion

GRAIL, Inc. (NASDAQ: GRAL) stands as a prominent player in the healthcare sector, specializing in diagnostics and research. With its core offering, Galleri—a multi-cancer early detection..

Liquidia Corporation (LQDA) Stock Analysis: Exploring Growth Potential in Rare Cardiopulmonary Therapeutics

Liquidia Corporation (NASDAQ: LQDA) is making waves in the healthcare sector with its significant advancements in the treatment of rare cardiopulmonary diseases. Trading at $83.85, the..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 20% Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH) is drawing investor interest as it stands at the crossroads of healthcare and industrial injury prevention services. This Houston-based company,..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 23% Upside Potential Amid Robust Revenue Growth

Phreesia, Inc. (PHR), a prominent player in the healthcare sector, specializes in providing an integrated SaaS-based software and payment platform designed to streamline operations for healthcare..

Search

Funds

August 4, 2026

Search

Funds

August 4, 2026

FTSE 100

Funds